Allspring Global Investments Holdings LLC Trims Stock Position in Cabot Corporation $CBT

Allspring Global Investments Holdings LLC trimmed its stake in Cabot Corporation (NYSE:CBTFree Report) by 45.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,187 shares of the specialty chemicals company’s stock after selling 16,795 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Cabot were worth $1,520,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Elevation Point Wealth Partners LLC purchased a new stake in Cabot in the second quarter worth about $28,000. Parkside Financial Bank & Trust grew its holdings in shares of Cabot by 95.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 189 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Cabot by 52.4% in the 2nd quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company’s stock valued at $55,000 after purchasing an additional 251 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in Cabot by 344.3% in the second quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock worth $61,000 after purchasing an additional 630 shares during the period. Institutional investors own 93.18% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. JPMorgan Chase & Co. decreased their price target on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. Mizuho boosted their price objective on shares of Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. Jefferies Financial Group reaffirmed a “buy” rating and set a $81.00 target price on shares of Cabot in a research note on Thursday. Finally, UBS Group reiterated a “buy” rating and set a $81.00 price objective on shares of Cabot in a research note on Thursday. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $74.00.

View Our Latest Report on CBT

Cabot Price Performance

Shares of CBT opened at $71.82 on Friday. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $92.89. The company has a market capitalization of $3.80 billion, a P/E ratio of 11.95, a price-to-earnings-growth ratio of 3.67 and a beta of 0.89. The firm has a 50 day moving average of $64.77 and a 200 day moving average of $72.30. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50.

Cabot (NYSE:CBTGet Free Report) last issued its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The business had revenue of $899.00 million for the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities research analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a yield of 2.5%. Cabot’s payout ratio is 29.95%.

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.